Cantor Fitzgerald raises WR Berkley target to $74
Cantor Fitzgerald analyst Ryan Tunis maintained a Neutral rating on WR Berkley and raised the price target to $74 from $70. This update aligns with recent upward revisions from Mizuho, Morgan Stanley, and Keefe, Bruyette & Woods, suggesting modest upside potential.

*this image is generated using AI for illustrative purposes only.
Cantor Fitzgerald analyst Ryan Tunis has maintained a Neutral rating for WR Berkley (NYSE: WRB) while raising the price target to $74 from $70. This adjustment follows a similar move by Mizuho analyst Yaron Kinar, who recently increased the valuation outlook to $72 from $68 while keeping a Neutral stance. The revised targets from multiple firms suggest modest upside potential based on current trading levels, reflecting a neutral view that balances potential risks and rewards for the insurance provider.
The Neutral ratings across these firms indicate expectations that the stock will perform in line with broader market averages. These updates provide specific benchmarks for the stock's near-term performance as analysts refine their outlooks for the insurance sector.
| Firm | Analyst | Rating | Previous Target | New Target |
|---|---|---|---|---|
| Morgan Stanley | Bob Huang | Equal-Weight | $72 | $75 |
| Keefe, Bruyette & Woods | Meyer Shields | Market Perform | $67 | $69 |
| Mizuho | Yaron Kinar | Neutral | $68 | $72 |
| Cantor Fitzgerald | Ryan Tunis | Neutral | $70 | $74 |
The updated price targets offer investors guidance on near-term valuation expectations.
What specific factors are driving the consensus among analysts to maintain Neutral ratings despite raising price targets?
How might WR Berkley's upcoming earnings report influence further adjustments to these price targets?
What potential risks could shift the Neutral sentiment to a more positive or negative outlook?































